Midori Takeda
Kagoshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of (20R)-protopanaxadiol from Panax ginseng as a novel anti-SARS-CoV-2 compound.
Journal: FEBS open bio
Published: January 09, 2026
Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors.
Journal: Scientific reports
Published: January 15, 2024
Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.
Journal: Journal of medical virology
Published: March 31, 2023
Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
Journal: Virus research
Published: June 29, 2019
Rab13 Is Involved in the Entry Step of Hepatitis C Virus Infection.
Journal: Acta medica Okayama
Published: April 21, 2016
Annexin A1 negatively regulates viral RNA replication of hepatitis C virus.
Journal: Acta medica Okayama
Published: April 23, 2015
New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.
Journal: PloS one
Published: April 11, 2013
Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.
Journal: The Journal of general virology
Published: March 30, 2012
Raloxifene inhibits hepatitis C virus infection and replication.
Journal: FEBS open bio
Published: January 01, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026